102 related articles for article (PubMed ID: 8492861)
21. Increased striatal 18F-dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome.
Otsuka M; Ichiya Y; Shima F; Kuwabara Y; Sasaki M; Fukumura T; Kato M; Masuda K; Goto I
J Neurol Sci; 1992 Sep; 111(2):195-9. PubMed ID: 1431986
[TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
Doudet DJ; Aigner TG; McLellan CA; Cohen RM
Psychiatry Res; 1992 Nov; 45(3):153-68. PubMed ID: 1283014
[TBL] [Abstract][Full Text] [Related]
23. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits.
Holthoff VA; Vieregge P; Kessler J; Pietrzyk U; Herholz K; Bönner J; Wagner R; Wienhard K; Pawlik G; Heiss WD
Ann Neurol; 1994 Aug; 36(2):176-82. PubMed ID: 8053653
[TBL] [Abstract][Full Text] [Related]
24. Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.
Sawle GV; Playford ED; Brooks DJ; Quinn N; Frackowiak RS
Brain; 1993 Aug; 116 ( Pt 4)():853-67. PubMed ID: 8353712
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography in manganese intoxication.
Wolters EC; Huang CC; Clark C; Peppard RF; Okada J; Chu NS; Adam MJ; Ruth TJ; Li D; Calne DB
Ann Neurol; 1989 Nov; 26(5):647-51. PubMed ID: 2510588
[TBL] [Abstract][Full Text] [Related]
26. A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.
Torstenson R; Tedroff J; Hartvig P; Fasth KJ; Långström B
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1142-9. PubMed ID: 10532639
[TBL] [Abstract][Full Text] [Related]
27. Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Howes OD; Montgomery AJ; Asselin MC; Murray RM; Valli I; Tabraham P; Bramon-Bosch E; Valmaggia L; Johns L; Broome M; McGuire PK; Grasby PM
Arch Gen Psychiatry; 2009 Jan; 66(1):13-20. PubMed ID: 19124684
[TBL] [Abstract][Full Text] [Related]
28. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
Honer M; Hengerer B; Blagoev M; Hintermann S; Waldmeier P; Schubiger PA; Ametamey SM
Nucl Med Biol; 2006 Jul; 33(5):607-14. PubMed ID: 16843835
[TBL] [Abstract][Full Text] [Related]
29. PET scan study on the dopaminergic system in a Japanese patient with hereditary progressive dystonia (Segawa's disease). Case report.
Okada A; Nakamura K; Snow BJ; Bhatt MH; Nomoto M; Osame M; Calne DB
Adv Neurol; 1993; 60():591-4. PubMed ID: 8420196
[No Abstract] [Full Text] [Related]
30. Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease.
Menza MA; Mark MH; Burn DJ; Brooks DJ
J Neuropsychiatry Clin Neurosci; 1995; 7(2):176-9. PubMed ID: 7626960
[TBL] [Abstract][Full Text] [Related]
31. Striatal dopamine during sensorial stimulations: a [18F]FDOPA PET study in human and cats.
Hassoun W; Thobois S; Ginovart N; Garcia-Larrea L; Cavorsin ML; Guillouet S; Bonnefoi F; Costes N; Lavenne F; Martin JP; Broussolle E; Leviel V
Neurosci Lett; 2005 Jul 22-29; 383(1-2):63-7. PubMed ID: 15936513
[TBL] [Abstract][Full Text] [Related]
32. Clinical heterogeneity of dopa-responsive dystonia: PET observations.
Takahashi H; Snow BJ; Nygaard TG; Calne DB
Adv Neurol; 1993; 60():586-90. PubMed ID: 8420195
[TBL] [Abstract][Full Text] [Related]
33. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
Pal PK; Leung J; Hedrich K; Samii A; Lieberman A; Nausieda PA; Calne DB; Breakefield XO; Klein C; Stoessl AJ
Mov Disord; 2002 Jul; 17(4):789-94. PubMed ID: 12210877
[TBL] [Abstract][Full Text] [Related]
34. n-Hexane-induced parkinsonism: pathogenetic hypotheses.
Pezzoli G; Antonini A; Barbieri S; Canesi M; Perbellini L; Zecchinelli A; Mariani CB; Bonetti A; Leenders KL
Mov Disord; 1995 May; 10(3):279-82. PubMed ID: 7651443
[TBL] [Abstract][Full Text] [Related]
35. [18F]-6-L-fluorodopa PET studies of graft and host dopaminergic function following fetal mesencephalic transplantation.
Sawle GV
Adv Neurol; 1993; 60():715-20. PubMed ID: 8420216
[No Abstract] [Full Text] [Related]
36. Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.
Leenders KL; Palmer AJ; Quinn N; Clark JC; Firnau G; Garnett ES; Nahmias C; Jones T; Marsden CD
J Neurol Neurosurg Psychiatry; 1986 Aug; 49(8):853-60. PubMed ID: 3091770
[TBL] [Abstract][Full Text] [Related]
37. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
[TBL] [Abstract][Full Text] [Related]
38. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
Dethy S; Van Blercom N; Damhaut P; Wikler D; Hildebrand J; Goldman S
Mov Disord; 1998 Mar; 13(2):275-80. PubMed ID: 9539341
[TBL] [Abstract][Full Text] [Related]
39. Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease.
Jeon B; Kim JM; Jeong JM; Kim KM; Chang YS; Lee DS; Lee MC
J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):60-4. PubMed ID: 9667562
[TBL] [Abstract][Full Text] [Related]
40. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.
Cropley VL; Fujita M; Bara-Jimenez W; Brown AK; Zhang XY; Sangare J; Herscovitch P; Pike VW; Hallett M; Nathan PJ; Innis RB
Psychiatry Res; 2008 Jul; 163(2):171-82. PubMed ID: 18504119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
